search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


PRescription Optimization of Psychotropic drugs in Elderly nuRsing home patients with dementia (PROPER study).


- candidate number13199
- NTR NumberNTR3569
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR2-aug-2012
- Secondary IDs4041600989025 ZonMw
- Public TitlePRescription Optimization of Psychotropic drugs in Elderly nuRsing home patients with dementia (PROPER study).
- Scientific TitlePRescription Optimization of Psychotropic drugs in Elderly nuRsing home patients with dementia.
- ACRONYMPROPER study
- hypothesisThe intervention increases the frequency of appropriate psychotropic medication use.
- Healt Condition(s) or Problem(s) studiedPsychotropic medication, Nursing home, Dementia
- Inclusion criteriaAll or a random selection of at least 15 nursing home patients of dementia special care units participating in the study.
- Exclusion criteriaObjection to participation in this study.
- mec approval receivedyes
- multicenter trialyes
- randomisedyes
- masking/blindingNone
- controlActive
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-sep-2012
- planned closingdate31-jul-2014
- Target number of participants360
- InterventionsStructured, 6-monthly medication review including training/education, control is usual care.

Nursing homes randomized to the intervention group, will implement a structured and repeated medication review. This comprises training on the implementation of medication reviews, and the actual conduct of the medication reviews per individual patient. The training consists of four sessions: a kick-off meeting, a medication review course and two evaluation sessions. The training will be given by the Dutch Institute for Rational Use of Medicine (IVM). Medication reviews are conducted shortly after the 0, 6, and 12-month assessments and subsequent training sessions. In the medication reviews, the pharmacist, physician and nurse will discuss all medication of the individual patients. In nursing homes randomized to the control group, usual care is continued.
- Primary outcomePrevalence of patients with appropriate psychotropic medication use.
- Secondary outcomeNeuropsychiatric symptoms:
Neuropsychiatric Inventory-Questionaire (NPI-Q), Cohen-Mansfield Agitation Inventory (CMAI), Nijmegen Observer-Rated Depression scale (NORD), Depression Rating Scale (DRS).

Quality of life:
Qualidem, Revised Index Social Engagement (RISE).

Activities of daily living:
Minimum Data Set-Activities of Daily Living-Self-Performance Hierarchy (MDS-ADL-SPH).

Side effects:
Short Side effect Scale for Psychotropic Drugs (3SPD).

Cognition:
Severe Impairment Battery-8 (SIB-8).
- Timepoints0, 6, 12, and 18 months.
- Trial web siteN/A
- statusplanned
- CONTACT FOR PUBLIC QUERIESMw. Dr. D.L. Gerritsen
- CONTACT for SCIENTIFIC QUERIESMw. Dr. D.L. Gerritsen
- Sponsor/Initiator University Medical Center St. Radboud
- Funding
(Source(s) of Monetary or Material Support)
ZON-MW, The Netherlands Organization for Health Research and Development
- PublicationsN/A
- Brief summaryIn this cluster randomised controlled pragmatic trial, the effect of a structured, 6-monthly medication review including training/education compared to usual care is studied in nursing home patients with dementia. The intervention is expected to improve appropriate psychotropic drug use and quality of life, and to decrease adverse events without increasing neuropsychiatric symptoms. The study is conducted in 26 dementia special care units of 13 nursing homes throughout the Netherlands.
- Main changes (audit trail)
- RECORD2-aug-2012 - 25-sep-2012


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl